← Back to Clinical Trials
Recruiting NCT05836103

NCT05836103 Testing the Impact of Smartphone-based Messaging to Support Young Adult Smoking Cessation

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05836103
Status Recruiting
Phase
Sponsor Johns Hopkins Bloomberg School of Public Health
Condition Tobacco Cigarette Smoking
Study Type INTERVENTIONAL
Enrollment 160 participants
Start Date 2024-10-22
Primary Completion 2026-11-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 30 Years
Study Type INTERVENTIONAL
Interventions
Smartphone-based intervention messages

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 160 participants in total. It began in 2024-10-22 with a primary completion date of 2026-11-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Clinical practice guidelines for smoking cessation emphasize cognitive behavioral therapy (CBT) to help patients develop coping strategies for urges. Mindfulness or Acceptance and Commitment Therapy (ACT) offer a different approach, which teaches smokers psychological flexibility through accepting negative experiences. While there is evidence for the efficacy of both CBT and Mindfulness/ACT smoking cessation interventions, it is unclear if these approaches are efficacious when implemented in real-time and with young adults. The overall goal of this proposal is to evaluate the efficacy of CBT and Mindfulness/ACT messages for young adults targeted at specific high-risk situations for smoking.

Eligibility Criteria

Inclusion Criteria: 1. live in the U.S. 2. read English; 3. are between 18 and 30 years of age; 4. own an iPhone or Android smartphone; 5. have smoked ≥100 cigarettes in their lives and currently smoke at least 3 cigarettes per day on 5 or more days of the week; 6. are planning to quit smoking within the next 30 days. Exclusion Criteria: * None

Contact & Investigator

Central Contact

Johannes Thrul, PhD

✉ jthrul@jhu.edu

📞 410-502-0925

Principal Investigator

Johannes Thrul, PhD

PRINCIPAL INVESTIGATOR

Johns Hopkins Bloomberg School of Public Health

Frequently Asked Questions

Who can join the NCT05836103 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 30 Years, studying Tobacco Cigarette Smoking. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05836103 currently recruiting?

Yes, NCT05836103 is actively recruiting participants. Contact the research team at jthrul@jhu.edu for enrollment information.

Where is the NCT05836103 trial being conducted?

This trial is being conducted at Baltimore, United States.

Who is sponsoring the NCT05836103 clinical trial?

NCT05836103 is sponsored by Johns Hopkins Bloomberg School of Public Health. The principal investigator is Johannes Thrul, PhD at Johns Hopkins Bloomberg School of Public Health. The trial plans to enroll 160 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology